The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Genetics of Parkinson's disease: An introspection of its journey towards precision medicine
Open accessAbstract
A substantial proportion of risk for Parkinson's disease (PD) is driven by genetics. Progress in understanding the genetic basis of PD has been significant. So far, highly-penetrant rare genetic alterations in SNCA, LRRK2, VPS35, PRKN, PINK1, DJ-1 and GBA have been linked with typical familial PD and common genetic variability at 90 loci have been linked to risk for PD. In this review, we outline the journey thus far of PD genetics, highlighting how significant advances have improved our knowledge of the genetic basis of PD risk, onset and progression. Despite remarkable progress, our field has yet to unravel how genetic risk variants disrupt biological pathways and molecular networks underlying the pathobiology of the disease. We highlight that currently identified genetic risk factors only represent a fraction of the likely genetic risk for PD. Identifying the remaining genetic risk will require us to diversify our efforts, performing genetic studies across different ancestral groups. This work will inform us on the varied genetic basis of disease across populations and also aid in fine mapping discovered loci. If we are able to take this course, we foresee that genetic discoveries in PD will directly influence our ability to predict disease and aid in defining etiological subtypes, critical steps for the implementation of precision medicine for PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The UK Biobank resource with deep phenotyping and genomic data
Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L. T., Sharp, K., Motyer, A., Vukcevic, D., Delaneau, O., O’Connell, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0579-z · Cited by 8,876
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Self-citationAlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Nalls, M. A., Blauwendraat, C., Vallerga, C. L., Heilbron, K., Bandres-Ciga, S., Chang, D., Tan, M., Kia, D. A., Noyce, A. J., Xue, A., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30320-5 · Cited by 2,454
Self-citationα-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
The Emerging Evidence of the Parkinson Pandemic
Dorsey, E. R., Sherer, T., Okun, M. S., & Bloem, B. R. (2018) · Journal of Parkinson’s Disease · doi:10.3233/jpd-181474 · Cited by 1,977
Genomics is failing on diversity
Popejoy, A. B., & Fullerton, S. M. (2016) · Nature · doi:10.1038/538161a · Cited by 1,924
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
Self-citationDrosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Self-citationIncidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity
Van Den Eeden, S. K. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg068 · Cited by 1,747
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705
Self-citationThe mystery of missing heritability: Genetic interactions create phantom heritability
Zuk, O., Hechter, E., Sunyaev, S. R., & Lander, E. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119675109 · Cited by 1,542
Detecting gene–gene interactions that underlie human diseases
Cordell, H. J. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2579 · Cited by 1,350
Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.485 · Cited by 1,324
PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity
Kane, L. A., Lazarou, M., Fogel, A. I., Li, Y., Yamano, K., Sarraf, S. A., Banerjee, S., & Youle, R. J. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201402104 · Cited by 1,298
Rare and common variants: twenty arguments
Gibson, G. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3118 · Cited by 1,278
A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Chang, D., Nalls, M. A., Hallgrímsdóttir, I. B., Hunkapiller, J., van der Brug, M., Cai, F., International Parkinson's Disease Genomics Consortium, 23andMe Research Team, Kerchner, G. A., Ayalon, G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3955 · Cited by 1,112
Self-citationCausal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease
Ibáñez, P., Bonnet, A.-M., Débarges, B., Lohmann, E., Tison, F., Agid, Y., Dürr, A., Brice, A., & Pollak, P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17104-3 · Cited by 1,044
Parkinson's disease: from monogenic forms to genetic susceptibility factors
Lesage, S., & Brice, A. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp012 · Cited by 945
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866
The “All of Us” Research Program
(2019) · New England Journal of Medicine · doi:10.1056/nejmc1912496 · Cited by 843
Hamza, T. H., Zabetian, C. P., Tenesa, A., Laederach, A., Montimurro, J., Yearout, D., Kay, D. M., Doheny, K. F., Paschall, J., Pugh, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.642 · Cited by 784
Meta‐analysis of early nonmotor features and risk factors for Parkinson disease
Noyce, A. J., Bestwick, J. P., Silveira‐Moriyama, L., Hawkes, C. H., Giovannoni, G., Lees, A. J., & Schrag, A. (2012) · Annals of Neurology · doi:10.1002/ana.23687 · Cited by 778
Update of the MDS research criteria for prodromal Parkinson's disease
Heinzel, S., Berg, D., Gasser, T., Chen, H., Yao, C., Postuma, R. B., & the MDS Task Force on the Definition of Parkinson's Disease (2019) · Movement Disorders · doi:10.1002/mds.27802 · Cited by 768
Study, T. L. C., Yang, J., Bakshi, A., Zhu, Z., Hemani, G., Vinkhuyzen, A. A. E., Lee, S. H., Robinson, M. R., Perry, J. R. B., Nolte, I. M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3390 · Cited by 745
G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndrome
Lesage, S., Anheim, M., Letournel, F., Bousset, L., Honoré, A., Rozas, N., Pieri, L., Madiona, K., Dürr, A., Melki, R., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23894 · Cited by 711
Pasanen, P., Myllykangas, L., Siitonen, M., Raunio, A., Kaakkola, S., Lyytinen, J., Tienari, P. J., Pöyhönen, M., & Paetau, A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.024 · Cited by 536
Enabling the genomic revolution in Africa
The H3Africa Consortium, Matovu, E., Bucheton, B., Chisi, J., Enyaru, J., Hertz-Fowler, C., Koffi, M., Macleod, A., Mumba, D., Sidibe, I., et al. (2014) · Science · doi:10.1126/science.1251546 · Cited by 519
Greenlandic Inuit show genetic signatures of diet and climate adaptation
Fumagalli, M., Moltke, I., Grarup, N., Racimo, F., Bjerregaard, P., Jørgensen, M. E., Korneliussen, T. S., Gerbault, P., Skotte, L., Linneberg, A., et al. (2015) · Science · doi:10.1126/science.aab2319 · Cited by 510
Mapping the Epigenetic Basis of Complex Traits
Cortijo, S., Wardenaar, R., Colomé-Tatché, M., Gilly, A., Etcheverry, M., Labadie, K., Caillieux, E., Hospital, F., Aury, J.-M., Wincker, P., et al. (2014) · Science · doi:10.1126/science.1248127 · Cited by 489
Kiely, A. P., Asi, Y. T., Kara, E., Limousin, P., Ling, H., Lewis, P., Proukakis, C., Quinn, N., Lees, A. J., Hardy, J., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1096-7 · Cited by 451
High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies
Hamdan, F. F., Myers, C. T., Cossette, P., Lemay, P., Spiegelman, D., Laporte, A. D., Nassif, C., Diallo, O., Monlong, J., Cadieux-Dion, M., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.09.008 · Cited by 445
Wright Willis, A., Evanoff, B. A., Lian, M., Criswell, S. R., & Racette, B. A. (2010) · Neuroepidemiology · doi:10.1159/000275491 · Cited by 436
Lesage, S., Drouet, V., Majounie, E., Deramecourt, V., Jacoupy, M., Nicolas, A., Cormier-Dequaire, F., Hassoun, S. M., Pujol, C., Ciura, S., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.01.014 · Cited by 434
Self-citationExcessive burden of lysosomal storage disorder gene variants in Parkinson’s disease
Robak, L. A., Jansen, I. E., van Rooij, J., Uitterlinden, A. G., Kraaij, R., Jankovic, J., Heutink, P., Shulman, J. M., International Parkinson’s Disease Genomics Consortium (IPDGC), Nalls, M. A., et al. (2017) · Brain · doi:10.1093/brain/awx285 · Cited by 433
Self-citationEnvironmental risk factors and Parkinson's disease: An umbrella review of meta-analyses
Bellou, V., Belbasis, L., Tzoulaki, I., Evangelou, E., & Ioannidis, J. P. A. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.12.008 · Cited by 426
Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
Jellinger, K. A., & Korczyn, A. D. (2018) · BMC Medicine · doi:10.1186/s12916-018-1016-8 · Cited by 385
Functionally informed fine-mapping and polygenic localization of complex trait heritability
Weissbrod, O., Hormozdiari, F., Benner, C., Cui, R., Ulirsch, J., Gazal, S., Schoech, A. P., van de Geijn, B., Reshef, Y., Márquez-Luna, C., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-00735-5 · Cited by 364
A twin approach to unraveling epigenetics
Bell, J. T., & Spector, T. D. (2011) · Trends in Genetics · doi:10.1016/j.tig.2010.12.005 · Cited by 353
Funayama, M., Ohe, K., Amo, T., Furuya, N., Yamaguchi, J., Saiki, S., Li, Y., Ogaki, K., Ando, M., Yoshino, H., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70266-2 · Cited by 351
Beilina, A., Rudenko, I. N., Kaganovich, A., Civiero, L., Chau, H., Kalia, S. K., Kalia, L. V., Lobbestael, E., Chia, R., Ndukwe, K., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318306111 · Cited by 348
Self-citationThe impact of rare and low-frequency genetic variants in common disease
Bomba, L., Walter, K., & Soranzo, N. (2017) · Genome Biology · doi:10.1186/s13059-017-1212-4 · Cited by 344
The Parkinson's disease–linked proteins Fbxo7 and Parkin interact to mediate mitophagy
Burchell, V. S., Nelson, D. E., Sanchez-Martinez, A., Delgado-Camprubi, M., Ivatt, R. M., Pogson, J. H., Randle, S. J., Wray, S., Lewis, P. A., Houlden, H., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3489 · Cited by 341
Blauwendraat, C., Heilbron, K., Vallerga, C. L., Bandres‐Ciga, S., von Coelln, R., Pihlstrøm, L., Simón‐Sánchez, J., Schulte, C., Sharma, M., Krohn, L., et al. (2019) · Movement Disorders · doi:10.1002/mds.27659 · Cited by 338
Self-citationEpigenetic inheritance and the missing heritability
Trerotola, M., Relli, V., Simeone, P., & Alberti, S. (2015) · Human Genomics · doi:10.1186/s40246-015-0041-3 · Cited by 318
DNAJC13 mutations in Parkinson disease
Vilariño-Güell, C., Rajput, A., Milnerwood, A. J., Shah, B., Szu-Tu, C., Trinh, J., Yu, I., Encarnacion, M., Munsie, L. N., Tapia, L., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt570 · Cited by 313
Brockmann, K., Srulijes, K., Pflederer, S., Hauser, A., Schulte, C., Maetzler, W., Gasser, T., & Berg, D. (2015) · Movement Disorders · doi:10.1002/mds.26071 · Cited by 267
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
Liu, G., Boot, B., Locascio, J. J., Jansen, I. E., Winder‐Rhodes, S., Eberly, S., Elbaz, A., Brice, A., Ravina, B., van Hilten, J. J., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24781 · Cited by 263
Genetic risk factors in Parkinson’s disease
Billingsley, K. J., Bandres-Ciga, S., Saez-Atienzar, S., & Singleton, A. B. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2817-y · Cited by 249
Self-citationIs Pesticide Use Related to Parkinson Disease? Some Clues to Heterogeneity in Study Results
van der Mark, M., Brouwer, M., Kromhout, H., Nijssen, P., Huss, A., & Vermeulen, R. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1103881 · Cited by 238
Blauwendraat, C., Reed, X., Krohn, L., Heilbron, K., Bandres-Ciga, S., Tan, M., Gibbs, J. R., Hernandez, D. G., Kumaran, R., Langston, R., et al. (2020) · Brain · doi:10.1093/brain/awz350 · Cited by 236
Self-citationSolving the missing heritability problem
Young, A. I. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008222 · Cited by 234
Dominance Genetic Variation Contributes Little to the Missing Heritability for Human Complex Traits
Zhu, Z., Bakshi, A., Vinkhuyzen, A. A. E., Hemani, G., Lee, S. H., Nolte, I. M., van Vliet-Ostaptchouk, J. V., Snieder, H., Esko, T., Milani, L., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.01.001 · Cited by 224
Missing heritability of complex diseases: case solved?
Génin, E. (2020) · Human Genetics · doi:10.1007/s00439-019-02034-4 · Cited by 206
Nalls, M. A., McLean, C. Y., Rick, J., Eberly, S., Hutten, S. J., Gwinn, K., Sutherland, M., Martinez, M., Heutink, P., Williams, N. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00178-7 · Cited by 204
Cannon, J. R., & Greenamyre, J. T. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.06.025 · Cited by 189
Association between cigarette smoking and Parkinson’s disease: A meta-analysis
Li, X., Li, W., Liu, G., Shen, X., & Tang, Y. (2015) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2015.08.004 · Cited by 189
Noyce, A. J., Kia, D. A., Hemani, G., Nicolas, A., Price, T. R., De Pablo-Fernandez, E., Haycock, P. C., Lewis, P. A., Foltynie, T., Davey Smith, G., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002314 · Cited by 175
Self-citationIdentification of TMEM230 mutations in familial Parkinson's disease
Deng, H.-X., Shi, Y., Yang, Y., Ahmeti, K. B., Miller, N., Huang, C., Cheng, L., Zhai, H., Deng, S., Nuytemans, K., et al. (2016) · Nature Genetics · doi:10.1038/ng.3589 · Cited by 172
Is Parkinson’s disease a lysosomal disorder?
Klein, A. D., & Mazzulli, J. R. (2018) · Brain · doi:10.1093/brain/awy147 · Cited by 172
Caffeine Intake, Smoking, and Risk of Parkinson Disease in Men and Women
Liu, R., Guo, X., Park, Y., Huang, X., Sinha, R., Freedman, N. D., Hollenbeck, A. R., Blair, A., & Chen, H. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr451 · Cited by 170
Iwaki, H., Blauwendraat, C., Leonard, H. L., Kim, J. J., Liu, G., Maple‐Grødem, J., Corvol, J., Pihlstrøm, L., van Nimwegen, M., Hutten, S. J., et al. (2019) · Movement Disorders · doi:10.1002/mds.27845 · Cited by 170
Self-citationGBA-Associated Parkinson’s Disease and Other Synucleinopathies
Gan‐Or, Z., Liong, C., & Alcalay, R. N. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0860-4 · Cited by 167
Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells
Garretti, F., Agalliu, D., Lindestam Arlehamn, C. S., Sette, A., & Sulzer, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00303 · Cited by 162
Intracellular Cholesterol Trafficking and Impact in Neurodegeneration
Arenas, F., Garcia-Ruiz, C., & Fernandez-Checa, J. C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00382 · Cited by 158
Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
Billingsley, K. J., Barbosa, I. A., Bandrés‐Ciga, S., Quinn, J. P., Bubb, V. J., Deshpande, C., Botía, J. A., Reynolds, R. H., Zhang, D., Simpson, M. A., et al. (2019) · npj Parkinson s Disease · doi:10.1038/s41531-019-0080-x · Cited by 154
Self-citationHolmans, P., Moskvina, V., Jones, L., Sharma, M., Vedernikov, A., Büchel, F., Sadd, M., Brás, J., Bettella, F., Nicolaou, N., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds492 · Cited by 150
Self-citationSilveira, C. R. A., MacKinley, J. D., Coleman, K. K. L., Li, Z., Finger, E. C., Bartha, R., Morrow, S. A., Wells, J., BORRIE, M. J., Tirona, R. G., et al. (2019) · BMC Neurology · doi:10.1186/s12883-019-1252-3 · Cited by 149
Blauwendraat, C., Faghri, F., Pihlstrøm, L., Geiger, J. T., Elbaz, A., Lesage, S., Corvol, J., May, P., Nicolas, A., Abramzon, Y. A., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.05.009 · Cited by 145
Self-citationQuadri, M., Mandemakers, W., Grochowska, M. M., Masius, R., Geut, H., Fabrizio, E., Breedveld, G. J., Kuipers, D., Minneboo, M., Vergouw, L. J. M., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30179-0 · Cited by 143
Park, E. J., Grabińska, K. A., Guan, Z., Stránecký, V., Hartmannová, H., Hodaňová, K., Barešová, V., Sovová, J., József, L., Ondrušková, N., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.06.016 · Cited by 139
Integrated molecular landscape of Parkinson’s disease
Klemann, C. J. H. M., Martens, G. J. M., Sharma, M., Martens, M. B., Ole Isacson, A., Gasser, T., Visser, J. E., & Poelmans, G. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-017-0015-3 · Cited by 137
The effect of LRRK2 loss-of-function variants in humans
Whiffin, N., Armean, I. M., Kleinman, A., Marshall, J. L., Minikel, E. V., Goodrich, J. K., Quaife, N. M., Cole, J. B., Wang, Q. S., Karczewski, K. J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0893-5 · Cited by 131
N370S ‐GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's disease
García‐Sanz, P., Orgaz, L., Bueno-Gil, G., Espadas, I., Rodríguez‐Traver, E., Kulisevsky, J., Gutiérrez, A., Dávila, J. C., González‐Polo, R. A., Fuentes, J. M., et al. (2017) · Movement Disorders · doi:10.1002/mds.27119 · Cited by 129
l -Dopa-induced adverse effects in PD and dopamine transporter gene polymorphism
Kaiser, R., Höfer, A., Grapengiesser, A., Gasser, T., Kupsch, A. R., Roots, I., & Brockmöller, J. (2003) · Neurology · doi:10.1212/01.wnl.0000068009.32067.a1 · Cited by 126
Kuwahara, T., Inoue, K., D’Agati, V. D., Fujimoto, T., Eguchi, T., Saha, S., Wolozin, B., Iwatsubo, T., & Abeliovich, A. (2016) · Scientific Reports · doi:10.1038/srep29945 · Cited by 125
Genome-wide association study of Parkinson’s disease in East Asians
Foo, J. N., Tan, L. C. S., Irwan, I. D., Au, W., Low, H. Q., Prakash, K., Ahmad‐Annuar, A., Bei, J., Chan, A. Y. Y., Chen, C., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw379 · Cited by 124
Ritchie, M. D., & Steen, K. V. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.04.05 · Cited by 115
NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases
Nalls, M. A., Brás, J., Hernandez, D. G., Keller, M. F., Majounie, E., Renton, A. E., Saad, M., Jansen, I. E., Guerreiro, R. J., Lubbe, S. J., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.028 · Cited by 101
Self-citationBiałecka, M. A., Kurzawski, M., Kłodowska-Duda, G. A., Opala, G., Tan, E., & Droździk, M. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328306c2f2 · Cited by 101
Coding mutations in NUS1 contribute to Parkinson’s disease
Guo, J., Zhang, L., Li, K., Mei, J., Xue, J., Chen, J., Tang, X., Shen, L. H., Jiang, H. F., Chen, C., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809969115 · Cited by 98
Alcohol intake and risk of Parkinson's disease: A meta‐analysis of observational studies
Zhang, D., Jiang, H. F., & Xie, J. (2014) · Movement Disorders · doi:10.1002/mds.25863 · Cited by 96
DJ‐1, PINK1, and their effects on mitochondrial pathways
Cookson, M. (2010) · Movement Disorders · doi:10.1002/mds.22713 · Cited by 92
The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease
Bandres‐Ciga, S., Saez‐Atienzar, S., Bonet‐Ponce, L., Billingsley, K., Vitale, D., Blauwendraat, C., Gibbs, J. R., Pihlstrøm, L., Gan‐Or, Z., The International Parkinson's Disease Genomics Consortium (IPDGC), et al. (2019) · Movement Disorders · doi:10.1002/mds.27614 · Cited by 90
Self-citationClark, L. N., Nicolai, A., Afridi, S. K., Harris, J. M., Mejia‐Santana, H., Strug, L. J., COTE, L. J., Louis, E. D., Andrews, H., Waters, C., et al. (2004) · Movement Disorders · doi:10.1002/mds.20320 · Cited by 89
Brain cholesterol metabolism and Parkinson's disease
Huang, X., Sterling, N. W., Du, G., Sun, D., Stetter, C. M., Kong, L., Zhu, Y., Neighbors, J. D., Lewis, M. M., Chen, H., et al. (2019) · Movement Disorders · doi:10.1002/mds.27609 · Cited by 89
Harrison, K. D., Miao, R. Q., Fernandez-Hernando, C. F., Suárez, Y., Dávalos, A., & Sessa, W. C. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.07.003 · Cited by 88
Rieck, M., Schuh, A. F. S., Altmann, V., Francisconi, C. L. M., Fagundes, P. T., Monte, T. L., Callegari-Jacques, S. M., Rieder, C. R. D. M., & Hutz, M. H. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.149 · Cited by 83
A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci
Singleton, A., & Hardy, J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr358 · Cited by 83
Self-citationPREDICT‐PD: An online approach to prospectively identify risk indicators of Parkinson's disease
Noyce, A. J., R’Bibo, L., Peress, L., Bestwick, J. P., Adams-Carr, K. L., Mencacci, N. E., Hawkes, C. H., Masters, J. M., Wood, N. W., Hardy, J., et al. (2017) · Movement Disorders · doi:10.1002/mds.26898 · Cited by 80
The Parkinson's Disease Mendelian Randomization Research Portal
Noyce, A. J., Bandrés‐Ciga, S., Kim, J., Heilbron, K., Kia, D. A., Hemani, G., Xue, A., Lawlor, D. A., Smith, G. D., Durán, R., et al. (2019) · Movement Disorders · doi:10.1002/mds.27873 · Cited by 80
Self-citationParkinson’s Disease in Sub-Saharan Africa: A Review of Epidemiology, Genetics and Access to Care
Williams, U. E., Bandmann, O., & Walker, R. W. (2018) · Journal of Movement Disorders · doi:10.14802/jmd.17028 · Cited by 79
Bandrés‐Ciga, S., Ahmed, S., Sabir, M. S., Blauwendraat, C., Adarmes-Gómez, A. D., Bernal‐Bernal, I., Bonilla‐Toribio, M., Buiza‐Rueda, D., Carrillo, F., Carrión‐Claro, M., et al. (2019) · Movement Disorders · doi:10.1002/mds.27864 · Cited by 75
Self-citationNiemann-Pick C Disease Gene Mutations and Age-Related Neurodegenerative Disorders
Zech, M., Nübling, G., Castrop, F., Jochim, A., Schulte, E. C., Mollenhauer, B., Lichtner, P., Peters, A., Gieger, C., Marquardt, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082879 · Cited by 70
Arylsulfatase A, a genetic modifier of Parkinson’s disease, is an α-synuclein chaperone
Lee, J. S., Kanai, K., Suzuki, M., Kim, W. S., Yoo, H. S., Fu, Y., Kim, D.-K., Jung, B. C., Choi, M.-S., Oh, K. W., et al. (2019) · Brain · doi:10.1093/brain/awz205 · Cited by 69
Cheshire, P., Bertram, K., Ling, H., et al. (2013) · Neurodegenerative Diseases · doi:10.1159/000351097 · Cited by 68
Masellis, M., Collinson, S., Freeman, N., Tampakeras, M., Levy, J., Tchelet, A., Eyal, E., Berkovich, E., Eliaz, R. E., Abler, V., et al. (2016) · Brain · doi:10.1093/brain/aww109 · Cited by 68
Leonard, H. L., Blauwendraat, C., Krohn, L., Faghri, F., Iwaki, H., Ferguson, G. D., Day-Williams, A., Stone, D. J., Singleton, A., Nalls, M. A., et al. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106283 · Cited by 68
Self-citationMultisystem Lewy body disease and the other parkinsonian disorders
Langston, J. W., Schüle, B., Rees, L., Nichols, R. J., & Barlow, C. (2015) · Nature Genetics · doi:10.1038/ng.3454 · Cited by 63
Why the missing heritability might not be in the DNA
Bourrat, P., Lu, Q., & Jablonka, E. (2017) · BioEssays · doi:10.1002/bies.201700067 · Cited by 62
Kia, D. A., Noyce, A. J., White, J., Speed, D., Nicolas, A., collaborators, I., Burgess, S., Lawlor, D. A., Smith, G. D., Singleton, A., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25294 · Cited by 62
Self-citationKrishnamoorthy, S., Rajan, R., Banerjee, M., Kumar, H., Sarma, G., Krishnan, S., Sarma, P. S., & Kishore, A. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.06.005 · Cited by 61
Deep brain stimulation for monogenic Parkinson’s disease: a systematic review
Kuusimäki, T., Korpela, J., Pekkonen, E., Martikainen, M. H., Antonini, A., & Kaasinen, V. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09181-8 · Cited by 57
Lawlor, D. A., Wade, K. H., Borges, M. C., Palmer, T., Hartwig, F. P., Hemani, G., & Bowden, J. (2019) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/6yzs7 · Cited by 56
SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population
Trotta, L., Guella, I., Soldà, G., Sironi, F. M., Tesei, S., Canesi, M., Pezzoli, G., Goldwurm, S., Duga, S., & Asselta, R. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.10.014 · Cited by 53
Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness
Cieri, D., Brini, M., & Calí, T. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.153 · Cited by 53
LARGE‐PD: Examining the genetics of Parkinson's disease in Latin America
Zabetian, C. P., & Mata, I. F. (2017) · Movement Disorders · doi:10.1002/mds.27081 · Cited by 53
Siitonen, A., Nalls, M. A., Hernandez, D. G., Gibbs, J. R., Ding, J., Ylikotila, P., Edsall, C. W., Singleton, A., & Majamaa, K. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.01.019 · Cited by 50
Self-citationDJ1 represses glycolysis and cell proliferation by transcriptionally up-regulatingpink1
Requejo-Aguilar, R., López-Fabuel, I., Jiménez-Blasco, D., Fernández, E., Almeida, Á., & Bolaños, J. P. (2015) · Biochemical Journal · doi:10.1042/bj20141025 · Cited by 49
Heritability and genetic variance of dementia with Lewy bodies
Guerreiro, R. J., Escott‐Price, V., Hernandez, D. G., Kun‐Rodrigues, C., Ross, O. A., Orme, T., Neto, J. L., Carmona, S., Dehghani, N., Eicher, J. D., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.04.004 · Cited by 48
Self-citationEarly-onset Parkinson disease caused by a mutation in CHCHD2 and mitochondrial dysfunction
Lee, R. G., Sedghi, M., Salari, M., Shearwood, A.-M. J., Stentenbach, M., Kariminejad, A., Goullée, H., Rackham, O., Laing, N. G., Tajsharghi, H., et al. (2018) · Neurology Genetics · doi:10.1212/nxg.0000000000000276 · Cited by 47
Is Parkinson’s Disease Acquired or Inherited?
Duvoisin, R. C. (1984) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710004631x · Cited by 37
Chen, J., Chen, Y., & Pu, J. (2018) · European Neurology · doi:10.1159/000488938 · Cited by 36
Zhang, M., Mu, H., Shang, Z., Kang, K., Lv, H., Duan, L., Li, J., Chen, X., Teng, Y., Jiang, Y., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.11.004 · Cited by 32
Fernández‐Santiago, R., Martín‐Flores, N., Antonelli, F., Cerquera‐Cleves, C., Moreno, V., Bandrés‐Ciga, S., Manduchi, E., Tolosa, E. S., Singleton, A., Moore, J. H., et al. (2019) · Movement Disorders · doi:10.1002/mds.27770 · Cited by 31
Self-citationGiri, A., Mok, K. Y., Jansen, I. E., Sharma, M., Tesson, C., Mangone, G., Lesage, S., Brás, J., Shulman, J. M., Sheerin, U., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.10.004 · Cited by 28
The All of Us Research Program: One size does not fit all
(2018) · The Nurse Practitioner · doi:10.1097/01.npr.0000541472.39043.62 · Cited by 26
LRP10 in autosomal‐dominant Parkinson's disease
Chen, Y., Cen, Z., Zheng, X., Pan, Q., Chen, X., Zhu, L., Chen, S. X., Wu, H., Xie, F., Wang, H., et al. (2019) · Movement Disorders · doi:10.1002/mds.27693 · Cited by 26
A powerful and efficient two-stage method for detecting gene-to-gene interactions in GWAS
Pecanka, J., Jonker, M. A., Bochdanovits, Z., & van der Vaart, A. (2017) · Biostatistics · doi:10.1093/biostatistics/kxw060 · Cited by 21
Bandrés‐Ciga, S., Ahmed, S., Sabir, M. S., Blauwendraat, C., Adarmes-Gómez, A. D., Bernal‐Bernal, I., Bonilla‐Toribio, M., Buiza‐Rueda, D., Carrillo, F., Carrión‐Claro, M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/609016 · Cited by 21
Self-citationAssessment of Parkinson's disease risk loci in Greece
Kara, E., Xiromerisiou, G., Spanaki, C., Bozi, M., Koutsis, G., Πάνας, Μ., Dardiotis, E., Ralli, S., Brás, J., Letson, C., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.011 · Cited by 19
Self-citationGuerreiro, R. J., Orme, T., Neto, J. L., Brás, J., Guerreiro, R. J., Hardy, J., Kun‐Rodrigues, C., Darwent, L., Orme, T., Neto, J. L., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30399-5 · Cited by 19
Self-citationVergouw, L. J. M., Ruitenberg, A., Wong, T. H., Melhem, S., Breedveld, G. J., Criscuolo, C., Michele, G. D., de Jong, F. J., Bonifati, V., Swieten, J. C. V., et al. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.05.037 · Cited by 19
Evaluating the role of TMEM230 variants in Parkinson's disease
Baumann, H., Wolff, S., Münchau, A. M., Hagenah, J. M., Lohmann, K., & Klein, C. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.12.015 · Cited by 18
Kia, D. A., Sabir, M. S., Ahmed, S., Trinh, J., Bandrés‐Ciga, S., Noyce, A. J., Kaiyrzhanov, R. B., Middlehurst, B., Kia, D. A., Tan, M. M. X., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30401-0 · Cited by 18
Self-citationSequencing TMEM230 in Chinese patients with sporadic or familial Parkinson's disease
Yang, X., An, R., Xi, J., Zheng, J., Chen, Y., Huang, H., Tian, S., Zhao, Q., Ning, P., & Xu, Y. (2017) · Movement Disorders · doi:10.1002/mds.26996 · Cited by 17
Doubts about TMEM230 as a gene for parkinsonism
Farrer, M. J. (2019) · Nature Genetics · doi:10.1038/s41588-019-0354-6 · Cited by 17
Genome-wide estimates of heritability and genetic correlations in essential tremor
Díez-Fairén, M., Bandrés‐Ciga, S., Houle, G., Nalls, M. A., Girard, S., Dion, P. A., Blauwendraat, C., Singleton, A., Rouleau, G. A., & Pástor, P. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.05.002 · Cited by 17
Self-citationShi, C., Luo, H., Fan, Y., Li, Y., & Xu, Y. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30402-2 · Cited by 16
Tesson, C., Brefel‐Courbon, C., Corvol, J., Lesage, S., Brice, A., Agid, Y., Anheim, M., Bonnet, A. M., Borg, M., Brefel‐Courbon, C., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30400-9 · Cited by 16
Alpha‐synuclein triggers T‐cell response. Is Parkinson's disease an autoimmune disorder?
Bandrés‐Ciga, S., & Cookson, M. R. (2017) · Movement Disorders · doi:10.1002/mds.27116 · Cited by 14
TMEM230 Mutations Are Rare in Han Chinese Patients with Autosomal Dominant Parkinson’s Disease
Wei, Q., Ou, R., Zhou, Q., Chen, Y., Cao, B., Gu, X., Zhao, B., Wu, Y., Song, W., & Shang, H. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0542-2 · Cited by 12
Deng, H., Pericak‐Vance, M. A., & Siddique, T. (2019) · Nature Genetics · doi:10.1038/s41588-019-0355-5 · Cited by 12
Pihlstrøm, L., Schottlaender, L., Chelban, V., Houlden, H., Al‐Sarraj, S., Arzberger, T., Bettencourt, C., Bhatia, K. P., Dickson, D. W., Federoff, M., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30407-1 · Cited by 11
Self-citationTMEM230 variants in Parkinson’s disease
Iqbal, Z., & Toft, M. (2019) · Nature Genetics · doi:10.1038/s41588-019-0353-7 · Cited by 10
Fan, T.-S., Lin, C., Lin, H., Chen, M., & Wu, R. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32576 · Cited by 9
Cited by
Simuni, T., Chahine, L. M., Poston, K., Brumm, M., Buracchio, T., Campbell, M., Chowdhury, S., Coffey, C., Concha-Marambio, L., Dam, T., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00405-2 · Cited by 629
Self-citationMicroglia and astrocyte dysfunction in parkinson's disease
Kam, T.-I., Hinkle, J. T., Dawson, T. M., & Dawson, V. L. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105028 · Cited by 389
The Role of Oxidative Stress in Parkinson’s Disease
Chang, K.-H., & Chen, C.-M. (2020) · Antioxidants · doi:10.3390/antiox9070597 · Cited by 341
Treatment Options for Motor and Non-Motor Symptoms of Parkinson’s Disease
Church, F. C. (2021) · Biomolecules · doi:10.3390/biom11040612 · Cited by 290
Li, L., Acioglu, C., Heary, R. F., & Elkabes, S. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.10.007 · Cited by 283
Metadata
- Authors
- Bandres-Ciga, S., Diez-Fairen, M., Kim, J. J., & Singleton, A. B.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 137
- Pages
- 104782
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W3000974767
- Cited by
- 370
- References
- 144
- FWCI
- 21.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.